Corbus Pharmaceuticals Holdings, Inc. (CRBP) › Operating Cash FlowCorbus Pharmaceuticals Holdings, Inc. (CRBP) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: -$27.80M2018: -$30.07M2019: -$45.72M2020: -$99.69M2021: -$48.18M2022: -$37.54M2023: -$36.10M2024: -$41.79M2025: -$64.49M-$64.49M2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$64.49M-54.3%2024-$41.79M-15.8%2023-$36.10M+3.8%2022-$37.54M+22.1%2021-$48.18M+51.7%2020-$99.69M-118.0%2019-$45.72M-52.1%2018-$30.07M-8.2%2017-$27.80M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share